Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot self-selection trial of Aleve 24 Hour
2014-005305-20Phase 3
- Sponsor
- Bayer
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of naproxen in pain, sponsored by Bayer. Primary endpoint: Percentage of participants who selected naproxen sodium ER and expected their pain to last more than 12 hours.
02
Drugs
naproxen
03
Conditions
pain
Beyond the preview
Go deeper on 2014-005305-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005305-20.